- Home
- NBIX vs OHI Comparison
NBIX vs OHI Comparison
Compare NBIX & OHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- OHI
- Stock Information
- Founded
- NBIX 1992
- OHI 1992
- Country
- NBIX United States
- OHI United States
- Employees
- NBIX N/A
- OHI N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- OHI Real Estate Investment Trusts
- Sector
- NBIX Health Care
- OHI Real Estate
- Exchange
- NBIX Nasdaq
- OHI Nasdaq
- Market Cap
- NBIX 11.0B
- OHI 10.6B
- IPO Year
- NBIX 1996
- OHI N/A
- Fundamental
- Price
- NBIX $115.71
- OHI $35.93
- Analyst Decision
- NBIX Strong Buy
- OHI Buy
- Analyst Count
- NBIX 20
- OHI 9
- Target Price
- NBIX $163.20
- OHI $41.00
- AVG Volume (30 Days)
- NBIX 1.9M
- OHI 2.8M
- Earning Date
- NBIX 05-05-2025
- OHI 05-01-2025
- Dividend Yield
- NBIX N/A
- OHI 7.47%
- EPS Growth
- NBIX N/A
- OHI 44.22
- EPS
- NBIX 2.96
- OHI 1.60
- Revenue
- NBIX $2,412,600,000.00
- OHI $1,084,876,000.00
- Revenue This Year
- NBIX $15.36
- OHI $11.76
- Revenue Next Year
- NBIX $16.34
- OHI $4.85
- P/E Ratio
- NBIX $39.13
- OHI $22.42
- Revenue Growth
- NBIX 21.73
- OHI 11.29
- 52 Week Low
- NBIX $84.23
- OHI $30.48
- 52 Week High
- NBIX $157.98
- OHI $44.42
- Technical
- Relative Strength Index (RSI)
- NBIX 60.88
- OHI 36.74
- Support Level
- NBIX $105.45
- OHI $35.09
- Resistance Level
- NBIX $130.46
- OHI $39.14
- Average True Range (ATR)
- NBIX 4.31
- OHI 0.73
- MACD
- NBIX 1.96
- OHI -0.32
- Stochastic Oscillator
- NBIX 50.22
- OHI 15.93
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About OHI Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).